Fig. 2.
Comparison of cancer onset, tumor types, and patient demographics between R337H and non-R337H carriers. A) Kaplan–Meier curves showing the cumulative risks of R337H and non-R337H carriers of developing a (first) primary tumor; B) Cancer patterns in R337H and non-R337H carriers; C) Proportions of male (M) and female (F) carriers without reported tumors, diagnosed with 1 primary tumor or with 2 or more primary tumors in R337H and non-R337H cohorts.
